Spero Therapeutics, Inc.
NASDAQ:SPRO
1.37 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 22.806 | -46.415 | -89.756 | -78.28 | -60.925 | -41.662 | -39.886 | -32.641 | -13.153 |
| Depreciation & Amortization
| 0.367 | 0.869 | 0.646 | 0.761 | 0.75 | 0.409 | 0.363 | 0.279 | 0.011 |
| Deferred Income Tax
| -8.366 | 0 | 0.06 | -0.362 | -0.808 | 0 | 0.083 | -0.58 | -0.174 |
| Stock Based Compensation
| 7.932 | 9.123 | 9.43 | 4.888 | 3.776 | 2.749 | 1.427 | 0.18 | 0.021 |
| Change In Working Capital
| -70.375 | 22.087 | 12.901 | -13.392 | 6.831 | -1.071 | 0.443 | -0.792 | 0.17 |
| Accounts Receivables
| -0.461 | 1.547 | 3.832 | 2.176 | -7.085 | 1.405 | -2.518 | -0.294 | -0.01 |
| Inventory
| 0 | -1.547 | -3.832 | -2.176 | 7.085 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.761 | -0.484 | -0.053 | -2.975 | 0.564 | 0.084 | 2.349 | -0.644 | 0.671 |
| Other Working Capital
| -70.675 | 22.571 | 12.954 | -10.417 | 6.267 | -1.155 | -1.906 | -0.148 | -0.501 |
| Other Non Cash Items
| 14.641 | 6.605 | 2.372 | 0.513 | 0.356 | -0.05 | -1.541 | 4.595 | 3.517 |
| Operating Cash Flow
| -32.995 | -7.731 | -64.347 | -85.872 | -50.02 | -39.625 | -39.111 | -28.959 | -9.608 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0.039 | -0.157 | -0.314 | -2.436 | -0.027 | -0.83 | -0.232 |
| Acquisitions Net
| 0 | 0 | -0.039 | -10.627 | -29.844 | 83.156 | -1.175 | 0 | 0 |
| Purchases Of Investments
| 0 | -26.97 | -43.915 | -45.723 | -88.993 | -130.175 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 60.777 | 51.548 | 56.35 | 118.837 | 49.455 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 33.807 | 0.039 | 10.627 | 29.844 | -83.156 | -0.027 | 0 | 0 |
| Investing Cash Flow
| 0 | 33.807 | 7.672 | 10.47 | 29.53 | -83.156 | -0.027 | -0.83 | -0.232 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | -54.485 | -47.48 | -0.333 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.221 | 24.932 | 36.57 | 78.66 | 15.79 | 70.5 | 77.749 | 34.413 | 15.305 |
| Common Stock Repurchased
| 0 | 10.278 | 27.537 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.221 | -29.553 | 84.05 | 52.554 | 0.35 | -0.977 | 38.362 | 34.413 | 15.275 |
| Financing Cash Flow
| 0.221 | -29.553 | 84.05 | 130.881 | 16.14 | 69.523 | 116.111 | 34.413 | 15.275 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -32.774 | -3.477 | 27.375 | 55.479 | -4.35 | -53.258 | 76.973 | 4.624 | 5.435 |
| Cash At End Of Period
| 76.333 | 109.107 | 112.584 | 85.209 | 29.73 | 34.08 | 87.288 | 10.315 | 5.691 |